| 17beta-estradiol | decreases expression | ISO | RGD:737353 | 6480464 | Estradiol results in decreased expression of MME mRNA | CTD | PMID:19619570 PMID:16202921 |
| 17beta-estradiol | decreases expression | ISO | RGD:737353 | 6480464 | Estradiol results in decreased expression of MME mRNA | CTD | PMID:16202921 more ... |
| 17beta-estradiol | decreases expression | ISO | RGD:737353 | 6480464 | Estradiol results in decreased expression of MME mRNA | CTD | PMID:16202921 PMID:19619570 |
| 17beta-estradiol | multiple interactions | ISO | RGD:737353 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MME mRNA | CTD | PMID:19619570 |
| 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one | multiple interactions | ISO | RGD:737353 | 6480464 | Metribolone promotes the reaction [NDRG1 protein binds to MME protein] | CTD | PMID:17220478 |
| 2,2,2-tetramine | multiple interactions | ISO | RGD:3098 | 6480464 | Trientine inhibits the reaction [Streptozocin results in decreased expression of MME protein] | CTD | PMID:19634143 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:737353 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of MME mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:737353 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MME mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:3098 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MME mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:3098 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MME mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:3098 | 6480464 | AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of MME mRNA] | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MME mRNA | CTD | PMID:17586704 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:737353 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MME mRNA | CTD | PMID:16704738 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:737353 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MME mRNA | CTD | PMID:19619570 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | decreases expression | ISO | RGD:3098 | 6480464 | Puromycin Aminonucleoside results in decreased expression of MME protein | CTD | PMID:19885019 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | ISO | RGD:737353 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of MME mRNA | CTD | PMID:22079614 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:737353 | 6480464 | CSF3 protein promotes the reaction [Tretinoin results in increased expression of MME protein] | CTD | PMID:12627849 |
| all-trans-retinoic acid | increases expression | ISO | RGD:737353 | 6480464 | Tretinoin results in increased expression of MME mRNA | CTD | PMID:21934132 |
| all-trans-retinoic acid | increases expression | ISO | RGD:737353 | 6480464 | Tretinoin results in increased expression of MME protein | CTD | PMID:12627849 |
| ammonium chloride | affects expression | ISO | RGD:3098 | 6480464 | Ammonium Chloride affects the expression of MME mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:737353 | 6480464 | Benzo(a)pyrene results in decreased expression of MME mRNA | CTD | PMID:20064835 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of MME mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MME mRNA] | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:3098 | 6480464 | Benzo(a)pyrene results in decreased expression of MME mRNA | CTD | PMID:21839799 |
| bicalutamide | increases expression | ISO | RGD:737353 | 6480464 | bicalutamide results in increased expression of MME mRNA | CTD | PMID:15790403 |
| bisphenol A | decreases expression | ISO | RGD:737353 | 6480464 | bisphenol A results in decreased expression of MME mRNA | CTD | PMID:20678512 |
| candoxatrilat | decreases activity | ISO | RGD:737353 | 6480464 | candoxatrilat results in decreased activity of MME protein | CTD | PMID:18084312 |
| cisplatin | decreases expression | ISO | RGD:3098 | 6480464 | Cisplatin results in decreased expression of MME mRNA | CTD | PMID:22023808 |
| cobalt dichloride | decreases expression | ISO | RGD:737353 | 6480464 | cobaltous chloride results in decreased expression of MME mRNA | CTD | PMID:19320972 |
| cocaine | multiple interactions | ISO | RGD:3098 | 6480464 | naltrindole inhibits the reaction [[Thiorphan binds to and results in decreased activity of MME protein] which results in increased susceptibility to Cocaine] | CTD | PMID:19279569 |
| copper atom | decreases expression | ISO | RGD:3098 | 6480464 | Copper results in decreased expression of MME mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | ISO | RGD:3098 | 6480464 | Copper results in decreased expression of MME mRNA | CTD | PMID:22465980 |
| curcumin | decreases expression | ISO | RGD:737353 | 6480464 | Curcumin results in decreased expression of MME mRNA | CTD | PMID:17198877 |
| cyclosporin A | decreases expression | ISO | RGD:737353 | 6480464 | Cyclosporine results in decreased expression of MME mRNA | CTD | PMID:20106945 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of MME mRNA | CTD | PMID:17178593 |
| doxorubicin | decreases expression | ISO | RGD:737353 | 6480464 | Doxorubicin results in decreased expression of MME protein | CTD | PMID:16997790 |
| doxorubicin | affects response to substance | ISO | RGD:737353 | 6480464 | MME protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 |
| elemental selenium | multiple interactions | ISO | RGD:3098 | 6480464 | Selenium deficiency affects the expression of and affects the localization of MME protein | CTD | PMID:17109141 |
| folic acid | affects expression | ISO | RGD:737353 | 6480464 | Folic Acid affects the expression of MME mRNA | CTD | PMID:17320366 |
| fulvestrant | increases expression | ISO | RGD:737353 | 6480464 | fulvestrant results in increased expression of MME mRNA | CTD | PMID:16202921 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of MME mRNA | CTD | PMID:17178593 |
| hydralazine | multiple interactions | ISO | RGD:737353 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of MME mRNA | CTD | PMID:17183730 |
| lead(0) | multiple interactions | ISO | RGD:737353 | 6480464 | Lead results in decreased expression of and results in decreased activity of MME protein | CTD | PMID:21315759 |
| lead(0) | decreases expression | ISO | RGD:737353 | 6480464 | Lead results in decreased expression of MME mRNA | CTD | PMID:21315759 |
| mitomycin C | affects response to substance | ISO | RGD:737353 | 6480464 | MME protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 |
| morphine | multiple interactions | ISO | RGD:3098 | 6480464 | Naloxone inhibits the reaction [Morphine results in increased activity of MME protein]; more ... | CTD | PMID:10070497 |
| morphine | increases activity | ISO | RGD:3098 | 6480464 | Morphine results in increased activity of MME protein | CTD | PMID:10070497 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:3098 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of MME mRNA | CTD | PMID:18164116 |
| naloxone | multiple interactions | ISO | RGD:3098 | 6480464 | Naloxone inhibits the reaction [Morphine results in increased activity of MME protein] | CTD | PMID:10070497 |
| ochratoxin A | decreases expression | ISO | RGD:3098 | 6480464 | ochratoxin A results in decreased expression of MME mRNA | CTD | PMID:12700408 |
| phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of MME mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of MME mRNA | CTD | PMID:23091169 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of MME mRNA | CTD | PMID:19270015 PMID:19482888 |
| phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of MME mRNA | CTD | PMID:19482888 PMID:19270015 |
| phorbol 13-acetate 12-myristate | decreases expression | ISO | RGD:737353 | 6480464 | Tetradecanoylphorbol Acetate results in decreased expression of MME protein | CTD | PMID:16997790 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:3098 | 6480464 | Pregnenolone Carbonitrile results in increased expression of MME mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of MME mRNA | CTD | PMID:22698814 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | EXP | | 6480464 | NR1I2 protein promotes the reaction [Pregnenolone Carbonitrile results in decreased expression of MME mRNA] | CTD | PMID:22698814 |
| progesterone | decreases expression | ISO | RGD:737353 | 6480464 | Progesterone results in decreased expression of MME mRNA | CTD | PMID:18070364 |
| progesterone | affects expression | EXP | | 6480464 | Progesterone affects the expression of MME mRNA | CTD | PMID:17251523 |
| propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of MME mRNA | CTD | PMID:21278054 |
| resveratrol | increases activity | ISO | RGD:737353 | 6480464 | resveratrol results in increased activity of MME protein | CTD | PMID:16162502 |
| selenium atom | multiple interactions | ISO | RGD:3098 | 6480464 | Selenium deficiency affects the expression of and affects the localization of MME protein | CTD | PMID:17109141 |
| streptozocin | multiple interactions | ISO | RGD:3098 | 6480464 | Trientine inhibits the reaction [Streptozocin results in decreased expression of MME protein] | CTD | PMID:19634143 |
| streptozocin | decreases expression | ISO | RGD:3098 | 6480464 | Streptozocin results in decreased expression of MME protein | CTD | PMID:19634143 |
| tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of MME mRNA | CTD | PMID:20937368 |
| tert-butyl hydroperoxide | increases expression | ISO | RGD:737353 | 6480464 | tert-Butylhydroperoxide results in increased expression of MME mRNA | CTD | PMID:15336504 |
| testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of MME mRNA | CTD | PMID:21669218 |
| tetrachloromethane | increases expression | ISO | RGD:3098 | 6480464 | Carbon Tetrachloride results in increased expression of MME protein | CTD | PMID:16449355 |
| trans-resveratrol | increases activity | ISO | RGD:737353 | 6480464 | resveratrol results in increased activity of MME protein | CTD | PMID:16162502 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of MME mRNA | CTD | PMID:19042947 |
| valproic acid | multiple interactions | ISO | RGD:737353 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in increased expression of MME mRNA | CTD | PMID:17183730 |
| vincaleukoblastine | affects response to substance | ISO | RGD:737353 | 6480464 | MME protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 |